(Reuters) – The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca’s COVID-19 antibody cocktail Evusheld to provide protection against the …
By Raghav Mahobe and Julie Steenhuysen (Reuters) -Over 40% of COVID-19 cases in the United States are now caused by the highly contagious Omicron XBB.1.5, …
(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Friday estimated that by Oct. 8 nearly 14% of the circulating coronavirus variants …
(Reuters) – Pfizer Inc and its German partner BioNTech SE said on Wednesday they had started a mid-stage study of a modified COVID-19 vaccine which …
COPENHAGEN – The BA.2 subvariant of the Omicron coronavirus variant, which has quickly taken over in Denmark, is more transmissible than the more common BA.1 …